Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vaxxa AB's EBITDA for the
three
months ended in Jun. 2026 was kr0.64 Mil. Vaxxa AB's Revenue for the
three
months ended in Jun. 2026 was kr29.49 Mil. Therefore, Vaxxa AB's EBITDA margin for the quarter that ended in Jun. 2026 was 2.17%.
Vaxxa AB (XSAT:VAXXA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Vaxxa AB EBITDA Margin % Related Terms
Vaxxa AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Vaxxa AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:VAXXA vs UBER, SHOP, CRM: EBITDA Margin % Comparison
For the Software - Application subindustry, Vaxxa AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxxa AB EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Vaxxa AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Vaxxa AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxxa AB (XSAT:VAXXA) has a EBITDA Margin % of 2.17% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vaxxa AB and its competitors. According to the industry distribution chart, Vaxxa AB ranks #2042 out of 2820 companies in the Software industry, placing it in the top 72.4%.
Is Vaxxa AB's EBITDA Margin % too high?
Vaxxa AB's current EBITDA Margin % is 2.17%. The Software industry median EBITDA Margin % is 8.10. Vaxxa AB's value of 2.17% is 73.2% below this industry median. Based on the distribution chart, Vaxxa AB ranks #2042 out of 2820 companies in the Software industry, which is below the industry midpoint. Overall, Vaxxa AB has a GF Score™ of 25/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's EBITDA Margin % compare to UBER and SHOP?
According to the Software industry distribution chart, Vaxxa AB ranks #2042 out of 2820 companies for EBITDA Margin %. This places Vaxxa AB in the lower half of its industry. The industry median EBITDA Margin % is 8.10. Vaxxa AB's value of 2.17% is 73.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.10, based on 2,820 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaxxa AB's current EBITDA Margin % of 2.17% is 73.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vaxxa AB and its competitors. For the Software industry, the median EBITDA Margin % is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current EBITDA Margin % is 2.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Based on GuruFocus' analysis, Vaxxa AB (XSAT:VAXXA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.70, compared to a current price of kr0.50 — trading 29% below its estimated fair value. The current EBITDA Margin % is 2.17% and 73.2% below the Software industry median of 8.10. Vaxxa AB's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vaxxa AB (XSAT:VAXXA), the current EBITDA Margin % is 2.17% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaxxa AB (XSAT:VAXXA) Overvalued in 2026?
Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued.
The current stock price of kr0.50 is trading 29% below its estimated GF Value™ of kr0.70.
GuruFocus considers Vaxxa AB to be Modestly Undervalued.
Key valuation signals for XSAT:VAXXA:
EBITDA Margin %: 2.17%
GF Value™: kr0.70 vs. price of kr0.50 (29% below fair value)
Industry Position: 73.2% below the Software median (#2042 of 2820)
No single metric tells the full story. See the XSAT:VAXXA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
25GF Score
Get the complete analysis for XSAT:VAXXA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:VAXXA has been successfully added to your 
